Pactiv Evergreen (PTVE) agreed to be acquired and taken private by Novolex in an all-cash deal worth $6.7 billion, including debt, according to a joint Monday statement.
9. Pactiv Evergreen will "combine" with Novolex, the Charlotte-based company that bought the company in an all-cash transaction valued at $6.7 billion, the Dec. 9 news release announced.